• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
DMTK

DMTK

DermTech, Inc.

NASDAQHealthcareMedical - Diagnostics & ResearchUS

USD0.09

-0.01 (-11.32%)

Company Profile

CEO

Bret Christensen

IPO Date

2017-08-10

Sector

Healthcare

Industry

Medical - Diagnostics & Research

Exchange

NASDAQ

Country

US

Market Metrics

Open

$0.10

Prev. Close

$0.11

Day Low

$0.09

Day High

$0.10

52W Low

$0.04

52W High

$3.90

Market Cap

$0.00B

Volume

3.40M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentNeutral

Articles

10

Avg Positive

19.7%

Avg Negative

17.7%

Avg Neutral

62.4%

News Feed

DermTech Management to Participate at the Lake Street 2021 BIG5 Conference

Business Wire·8/31/2021·↑ positive

DermTech: Transforming The Melanoma Diagnosis Landscape

Seeking Alpha·8/31/2021·↑ positive

Got $100? 3 Smart Growth Stocks to Buy Right Now

The Motley Fool·8/30/2021·↑ positive

DermTech: Becoming More Appealing, Despite Nosebleed Valuation

Seeking Alpha·8/8/2021·↓ negative

DermTech, Inc. (DMTK) CEO John Dobak on Q2 2021 Results - Earnings Call Transcript

Seeking Alpha·8/4/2021·↓ negative

DermTech, Inc. (DMTK) Reports Q2 Loss, Tops Revenue Estimates

Zacks Investment Research·8/4/2021·↑ positive

Recap: DermTech Q2 Earnings

Benzinga·8/4/2021·↓ negative

DermTech to Announce Second Quarter Financial Results on August 4, 2021

Business Wire·7/21/2021·↑ positive

This Medical Device Company Is Changing the Game in Skin Cancer

The Motley Fool·7/18/2021·↑ positive

DermTech CEO John Dobak, M.D. Wins San Diego Business Journal CEO of the Year Award, Public Company, Medium Category

Business Wire·6/24/2021·↑ positive